Press "esc" to clear
Go to Advanced Search

Showing results

110 of 104523
venaseal.closuresystem.2018.jpg

Article ID: 700954

The Vascular Center at Mercy Medical Center Offers VenaSeal™ for Treating Venous Reflux Disease and Varicose Veins

Mercy Medical Center, Baltimore

Mercy Medical Center now offers the VenaSeal™ procedure as a new option for treating venous reflux disease and varicose veins.

Released:
21-Sep-2018 4:05 PM EDT

Channels:

Blood, Local - Maryland

Roley-Roberts-37.jpg

Article ID: 700949

Does Your Gut Hold the Key to Your Mind?

Ohio State University

Researchers around the world are exploring the gut/brain axis in the quest for knowledge about mood disorders such as depression, neurodegenerative diseases including Alzheimer’s and chronic conditions such as Crohn’s disease.

Released:
21-Sep-2018 4:05 PM EDT
Embargo will expire:
24-Sep-2018 3:00 PM EDT
Released to reporters:
21-Sep-2018 3:45 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Sep-2018 3:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 700939

Cancer, Pneumonia and Flu, and You

Fight Colorectal Cancer

With fall just around the corner, the Centers for Disease Control (CDC) expects flu season to begin ramping up within the next few months.

Released:
21-Sep-2018 3:30 PM EDT

Article ID: 700916

National Recognition for Einstein Montefiore Addiction Specialist

Albert Einstein College of Medicine

Dr. Chinazo Cunningham, M.D., M.S., a New York City-based expert in opioid use disorder will serve on a national board advising the CDC on best approaches to address the nation's opioid epidemic.

Released:
21-Sep-2018 3:30 PM EDT
Embargo will expire:
24-Sep-2018 11:00 AM EDT
Released to reporters:
21-Sep-2018 3:30 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Sep-2018 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

RS13959_LongZheng-1-scr.jpg

Article ID: 700944

A Trojan Horse Delivery of Possible Treatment for a Rare, Potentially Deadly, Blood-Clotting Disorder

University of Alabama at Birmingham

In proof-of-concept experiments, researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. Researchers deliver a therapeutic enzyme via the cellular equivalent of a Trojan Horse, using platelets to protect the key enzyme hidden inside.

Released:
21-Sep-2018 3:30 PM EDT
IMG_5593.JPG

Article ID: 700947

New Nanotherapy Offers Hope in Treating Drug-Resistant Renal Cell Carcinoma

Wayne State University Division of Research

A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.

Released:
21-Sep-2018 3:30 PM EDT
JuergenHahnfinal2.jpg

Article ID: 700932

Latest Research Hints at Predicting Autism Risk for Pregnant Mothers

Rensselaer Polytechnic Institute (RPI)

Researchers at Rensselaer Polytechnic Institute—led by Juergen Hahn, professor and head of biomedical engineering—are continuing to make remarkable progress with their research focused on autism spectrum disorder (ASD).

Released:
21-Sep-2018 1:05 PM EDT

Article ID: 700925

تقدم مبادئ توجيهية جديدة لمرض الانسداد الرئوي المزمن من الهيئة الدولية توصيات مُحدّثة

Mayo Clinic

روتشستر، مينيسوتا - يعتبر مرض الانسداد الرئوي الزمن (COPD) بالنسبة لكثير من الناس مرضًا مؤلمًا ومتكررًا يؤثر على القدرة على التنفس وجودة الحياة. بالرغم من كون مرض الانسداد الرئوي المزمن مرضًا من الممكن علاجه، إلا أنه يبقى السبب الثالث المؤدي للوفاة في الولايات المتحدة الأمريكية. وفي الإصدار الأخير لمجلة Mayo Clinic Proceedings، يلقي الباحثون نظره فاحصه عن كثب على النتائج والتوصيات الجديدة للمبادرة العالمية لمرض الانسداد الرئوي المزمن (GOLD) لتقييم آخر التطورات والنظر في دور العلاج بالنسبة لهذا المرض.

Released:
21-Sep-2018 12:05 PM EDT

Showing results

110 of 104523

Chat now!